经鼻高流量氧疗对特发性肺纤维化患者运动耐力的影响:随机交叉试验
本研究为单中心、开放标签、随机交叉试验,比较经鼻高流量氧疗(HFNC)与文丘里面罩(VM)对特发性肺纤维化(IPF)患者运动耐力的影响。
要点
- HFNC可延长IPF患者运动耐力时间。
- HFNC提高运动中最 lowest SpO2并减轻腿部疲劳。
- HFNC未显著改善呼吸困难及设备舒适度。
核心结论
- HFNC增加了存在运动诱发低氧血症的稳定期IPF患者的运动耐力。
主要发现
- HFNC较VM显著延长耐力时间(647.5 s [454.0-1014.8] vs. 577.5 s [338.0-861.5])。
- HFNC较VM显著提高最低SpO2(96.0% [95.0-98.0] vs. 94.0% [92.8-96.0])。
- HFNC较VM显著减轻等时点腿部疲劳(3.0 [1.6-4.0] vs. 5.0 [3.0-6.3])和终点腿部疲劳(4.0 [2.8-5.0] vs. 5.0 [3.8-6.3])。
- HFNC与VM在最大心率、等时点及终点呼吸困难、舒适度方面差异无统计学意义。
关键数值与推荐
- HFNC设置:流量60 L/min,FiO2 50%;VM设置:流量12 L/min,FiO2 50%。
- 运动试验为80%峰值功率的恒量症状限制性运动试验。
临床怎么用
- 对于稳定期IPF合并运动诱发低氧血症患者,运动康复时可考虑使用HFNC以延长运动时间并改善氧合及腿部疲劳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Exercise capacity in idiopathic pulmonary fibrosis (IPF) is limited by exercise-induced hypoxaemia. This study aimed to examine the effect of high-flow nasal cannula oxygen therapy (HFNC) on exercise tolerance in patients with IPF. METHODS: We conducted a single-centre, open-label, randomized crossover trial to compare HFNC and Venturi mask (VM) therapy in terms of exercise tolerance. Patients underwent constant-load symptom-limited exercise testing at 80% peak work rate with HFNC or a VM in a randomized order. The settings were 60 L/min and a 50% fraction of inspired oxygen (FiO2 ) for HFNC and 12 L/min and 50% FiO2 for VM. The primary outcome was endurance time, and the secondary outcomes were heart rate (HR), percutaneous oxygen saturation (SpO2 ), dyspnoea and leg fatigue, as determined by the modified Borg Scale at the isotime and endpoint, and the level of comfort while using the devices. RESULTS: Twenty-four participants (75.0% men; age, median [interquartile range]: 77.5 [68.8-83.0] years) were enrolled. Compared with VM, HFNC significantly improved the endurance time (647.5 s [454.0-1014.8] vs. 577.5 s [338.0-861.5]), minimum SpO2 (96.0% [95.0-98.0] vs. 94.0% [92.8-96.0]) and leg fatigue at the isotime (3.0 [1.6-4.0] vs. 5.0 [3.0-6.3]) and endpoint (4.0 [2.8-5.0] vs. 5.0 [3.8-6.3]). Differences in maximum HR, dyspnoea at the isotime and endpoint and comfort were non-significant between HFNC and VM therapy. CONCLUSION: HFNC increased exercise tolerance in patients with stable IPF experiencing exercise-induced hypoxaemia.
引用
- Harada J, Nagata K, Morimoto T, et al. Effect of high-flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial. Respirology. 2021. PMID: 34729862. doi:10.1111/resp.14176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。